Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)

National Institutes of Health

Federal funding opportunity PAR-25-247 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.